Next, to investigate whether PEAK1 expression is associated with the progression of NSCLC, we analyzed the correlations of PEAK1 expression with the clinicopathological characteristics of the lung cancer patients based on the immunohistochemical staining data (except for two cases of small cell lung cancer). Here, PEAK1 is linked to lung cancer.